Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: a systematic review and pooled analysis of data

V Nagaraja, K Schwarz, S Moss… - … Interventions, 2020 - Wiley Online Library
… of patients with chronic total occlusions, vein graft percutaneous coronary intervention (PCI), …
The stents used were primarily polytetrafluoroethylene (PTFE) (70%) and Papyrus (20.6%). …

Percutaneous coronary intervention

SQ Khan, PF Ludman - Medicine, 2022 - Elsevier
… some stents just 4 weeks, and can be considered in patients … For patients treated in the
context of an acute coronarystents do, however, offer the opportunity for some patients to …

Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …

MS Sabatine, BA Bergmark, SA Murphy, PT O'Gara… - The Lancet, 2021 - thelancet.com
… The optimal revascularisation strategy for patients with left main coronary artery … patients
treated with percutaneous coronary intervention (PCI) with drug-eluting stents versus coronary

[HTML][HTML] The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do

P Wang, H Qiao, RJ Wang, R Hou, J Guo - BMC Cardiovascular Disorders, 2020 - Springer
Percutaneous coronary intervention (PCI) is one of the main treatments for patients with CHD,
and intra-stent … ISR refers to the plaque within 5 mm of the edge of the stent after PCI and …

Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR)

D Collison, M Didagelos… - European Heart …, 2021 - academic.oup.com
… —Proportion of patients with final post-percutaneous coronary intervention fractional flow …
—Proportion of patients with final post-percutaneous coronary intervention fractional flow …

[HTML][HTML] … glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents

Y Zhu, K Liu, M Chen, Y Liu, A Gao, C Hu, H Li… - Cardiovascular …, 2021 - Springer
… retrospectively recruited patients who were admitted for ACS and underwent coronary
angiography at 6 to 24 months after successful DES-based percutaneous coronary intervention (…

Stent-related adverse events> 1 year after percutaneous coronary intervention

MV Madhavan, AJ Kirtane, B Redfors… - Journal of the American …, 2020 - jacc.org
… Contemporary drug-eluting stents (DES) have improved event-free survival in patients
undergoing percutaneous coronary intervention (PCI) compared with earlier stent designs (1,2). …

Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

M Galli, S Benenati, D Capodanno, F Franchi, F Rollini… - The Lancet, 2021 - thelancet.com
Background Whether guided selection of antiplatelet therapy in patients undergoing
percutaneous coronary intervention (PCI) is effective in improving outcomes compared with …

Recent advances in percutaneous coronary intervention

SP Hoole, P Bambrough - Heart, 2020 - heart.bmj.com
… in LMS intervention and in the assessment of failed stents, and … be employed to ensure full
stent expansion.18 In addition to … -art percutaneous coronary revascularization in patients with …

Bleeding avoidance strategies in percutaneous coronary intervention

D Capodanno, DL Bhatt, CM Gibson, S James… - Nature Reviews …, 2022 - nature.com
… Table 2 summarizes contemporary trials of coronary stent strategies for patients at high
risk of bleeding receiving a background short duration of DAPT. Two randomized, controlled …